Thermo Fisher Scientific
TMO
1,523 hedge funds and large institutions have $97.7B invested in Thermo Fisher Scientific in 2019 Q1 according to their latest regulatory filings, with 160 funds opening new positions, 520 increasing their positions, 618 reducing their positions, and 76 closing their positions.
111% more first-time investments, than exits
New positions opened: 160 | Existing positions closed: 76
25% more capital invested
Capital invested by funds: $78B → $97.7B (+$19.8B)
16% more funds holding in top 10
Funds holding in top 10: 128 → 149 (+21)
4% more funds holding
Funds holding: 1,458 → 1,523 (+65)
1.43% more ownership
Funds ownership: 88.12% → 89.55% (+1.4%)
8% less call options, than puts
Call options by funds: $210M | Put options by funds: $227M
16% less repeat investments, than reductions
Existing positions increased: 520 | Existing positions reduced: 618
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$722M |
| 2 |
BlackRock
New York
|
+$267M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$248M |
| 4 |
State Street
Boston,
Massachusetts
|
+$193M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$151M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$332M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$315M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$189M |
| 4 |
JP Morgan Chase
New York
|
-$174M |
| 5 |
Select Equity Group
New York
|
-$127M |
TMO Hedge Fund Activity: Q1 2019 in Review
1,523 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2019, worth a combined $97.7B — up 25% from $78B a quarter earlier.
Buyers outnumbered sellers: 160 funds opened new TMO positions and 76 closed out — a net gain of 84 holders — while 520 added to existing stakes and 618 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $722M. The largest seller was Longview Partners, exiting entirely with an estimated $332M sold.
- 1,523 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2019, up from 1,458 in Q4 2018.
- Funds reported $97.7B of Thermo Fisher Scientific stock for Q1 2019, up 25% quarter-over-quarter.
- 160 funds opened new Thermo Fisher Scientific positions in Q1 2019 and 76 closed out, a net change of +84 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2019 was Fidelity Investments, an estimated $722M added.
- The largest Thermo Fisher Scientific seller in Q1 2019 was Longview Partners, an estimated $332M sold.
Based on aggregated 13F filings for Q1 2019.